Search research articles
Contact Us
Filters
Showing results (61-70 of 134) with videos related to
Page
of 14
Sort By:
Thyroid : Official Journal of the American Thyroid Association
|
March 16, 2013
Clinical responses to vemurafenib in patients with metastatic papillary thyroid cancer harboring BRAF(V600E) mutation
Kevin B Kim, Maria E Cabanillas, Alexander J Lazar, et al.
Melanoma Research
|
December 21, 2010
Pelvic computed tomography scans for surveillance in patients with primary melanoma in the head and neck
Gladys C Alvarado, Nicholas E Papadopoulos, Wen-Jen Hwu, et al.
The Journal of Investigative Dermatology
|
April 6, 2024
The Molecular Evolution of Melanoma Distant Metastases
Vladimir Bezrookove, Sara Kianian, Lea McGeever, et al.
Cancer Epidemiology
|
October 23, 2018
Association between melanoma and renal-cell carcinoma for sequential diagnoses: A single-center retrospective study
Kunhwa Kim, Tong Han Chung, Carol J Etzel, et al.
Cancer Chemotherapy and Pharmacology
|
November 13, 2008
Phase I study of the combination of docetaxel, temozolomide and cisplatin in patients with metastatic melanoma
Kevin B Kim, Wen-Jen Hwu, Nicholas E Papadopoulos, et al.
Cancer
|
August 8, 2013
Clinical characteristics and outcomes with specific BRAF and NRAS mutations in patients with metastatic melanoma
Amanda D Bucheit, Erica Syklawer, John A Jakob, et al.
Scientific Reports
|
February 10, 2024
ARID2 mutations may relay a distinct subset of cutaneous melanoma patients with different outcomes
Favour A Akinjiyan, George Nassief, Jordan Phillipps, et al.
The American Journal of Dermatopathology
|
June 21, 2014
Histological features associated with vemurafenib-induced skin toxicities: examination of 141 cutaneous lesions biopsied during therapy
Jonathan L Curry, Michael T Tetzlaff, Kimberly Nicholson, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 15, 2015
Long term survival with cytotoxic T lymphocyte-associated antigen 4 blockade using tremelimumab
Zeynep Eroglu, Dae Won Kim, Xiaoyan Wang, et al.
JCO Precision Oncology
|
May 15, 2025
Phase II Study of Niraparib in Patients With Advanced Melanoma With Homologous Recombination Pathway Gene Mutations
Kevin B Kim, Pierre-Yves Desprez, David de Semir, et al.
Page
of 14
Search research articles
Search
Showing results (61-70 of 134) with videos related to
Sort By:
Page
of 14
Thyroid : Official Journal of the American Thyroid Association
|
March 16, 2013
Clinical responses to vemurafenib in patients with metastatic papillary thyroid cancer harboring BRAF(V600E) mutation
Kevin B Kim, Maria E Cabanillas, Alexander J Lazar, et al.
Melanoma Research
|
December 21, 2010
Pelvic computed tomography scans for surveillance in patients with primary melanoma in the head and neck
Gladys C Alvarado, Nicholas E Papadopoulos, Wen-Jen Hwu, et al.
The Journal of Investigative Dermatology
|
April 6, 2024
The Molecular Evolution of Melanoma Distant Metastases
Vladimir Bezrookove, Sara Kianian, Lea McGeever, et al.
Cancer Epidemiology
|
October 23, 2018
Association between melanoma and renal-cell carcinoma for sequential diagnoses: A single-center retrospective study
Kunhwa Kim, Tong Han Chung, Carol J Etzel, et al.
Cancer Chemotherapy and Pharmacology
|
November 13, 2008
Phase I study of the combination of docetaxel, temozolomide and cisplatin in patients with metastatic melanoma
Kevin B Kim, Wen-Jen Hwu, Nicholas E Papadopoulos, et al.
Cancer
|
August 8, 2013
Clinical characteristics and outcomes with specific BRAF and NRAS mutations in patients with metastatic melanoma
Amanda D Bucheit, Erica Syklawer, John A Jakob, et al.
Scientific Reports
|
February 10, 2024
ARID2 mutations may relay a distinct subset of cutaneous melanoma patients with different outcomes
Favour A Akinjiyan, George Nassief, Jordan Phillipps, et al.
The American Journal of Dermatopathology
|
June 21, 2014
Histological features associated with vemurafenib-induced skin toxicities: examination of 141 cutaneous lesions biopsied during therapy
Jonathan L Curry, Michael T Tetzlaff, Kimberly Nicholson, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 15, 2015
Long term survival with cytotoxic T lymphocyte-associated antigen 4 blockade using tremelimumab
Zeynep Eroglu, Dae Won Kim, Xiaoyan Wang, et al.
JCO Precision Oncology
|
May 15, 2025
Phase II Study of Niraparib in Patients With Advanced Melanoma With Homologous Recombination Pathway Gene Mutations
Kevin B Kim, Pierre-Yves Desprez, David de Semir, et al.
Page
of 14